Krsnaa Diagnostics shares gained over 3% in early trade on Monday after the company posted a healthy set of numbers for the July–September quarter (Q2 FY26). The diagnostics firm reported a steady improvement in revenue, profitability, and operating margins on a year-on-year basis, reflecting strong growth in its core business.
In Q2 FY26, Krsnaa Diagnostics’ consolidated revenue increased 10.5% to Rs 206 crore, compared to Rs 186 crore in the same quarter last year. The company’s EBITDA rose 19.4% to Rs 59 crore from Rs 49.4 crore a year ago, while EBITDA margins improved to 28.7% from 26.5%, showing operational efficiency and cost control.
Net profit for the quarter jumped 21.9% to Rs 23.9 crore, compared to Rs 19.6 crore in Q2 FY25.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
